December 13, 2013; Sacramento, CA, USA; UFC light heavyweight Jon Jones walks on stage for the announcement of the EA Sports UFC video game cover winner before the official weigh-in for UFC on FOX 9 at Sleep Train Arena. Mandatory Credit: Kyle Terada-USA TODAY Sports

MSAC releases statement regarding UFC 172 drug testing

Earlier this week, UFC light heavyweight champion Jon Jones announced that he was tested by the Maryland State Athletic Commission. His opponent for his UFC 172 title defense later this month, Glover Teixeira, was also tested leading up to the fight.

Now that news of the testing has surfaced, Patrick Panella, Executive Director of the Maryland State Athletic Commission, has confirmed the testing and released a statement on the matter.

“The Maryland State Athletic Commission respects, and maintains, the confidentiality of the out-of-competition random drug testing currently being conducted of professional MMA fighters Jon Jones and Glover Teixeira as they prepare to compete in UFC 172 on April 26, 2014 in Baltimore, Maryland,” the statement read, via

“Given that one or both of these individuals have commented publicly on such testing, the Maryland State Athletic Commission commends Mr. Jones and Mr. Teixeira, as well as Ultimate Fighting Championship (UFC), for their cooperation in supporting these additional drug testing measures.  The Maryland State Athletic Commission believes that such measures are significant and reflect favorably upon the sport of MMA.  We are looking forward to regulating UFC 172 in Baltimore.  To ensure the confidentiality of testing, there will be no further comment from the Maryland State Athletic Commission on this subject at this time.”

Both fighters had blood and urine tests, which the UFC paid for.

This is a huge step forward for drug testing in mixed martial arts and hopefully it is a standard that will be able to continue.

UFC 172 is set to take place April 26 in Baltimore, Maryland at the Baltimore Arena.

Tags: Glover Teixeira Jon Jones UFC UFC 172

comments powered by Disqus